Number	Group
6	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
6	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
6	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

General information

Protection concept against (sexual) violence against children and young people

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Is a protection concept in place? No
Note on the measure: Pflichtfortbildung Prävention sexualisierter Gewalt
Commentary on the protection concept: Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.

Drug therapy safety

Steering committee

Drug commission

Training of employees on AMTS related topics

Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)

Concepts for ensuring the error-free preparation of medications

Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen

Measures to minimise medication errors

Maßnahmen zur Vermeidung von Arzneimittelverwechslung
Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)

Measures to ensure seamless drug therapy after discharge

Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten

Instruments and measures

The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.

AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.

Special instrument-based equipment

Research & teaching

Job

FL04 - Project-related cooperation with colleges and universities

Explanation

FL08 - Editors of scientific journals/textbooks

Explanation

Albers, N. (2010): Klinische Untersuchung. In Hiort et al. (Hrsg.): Pädiatrische Endokrinologie und Diabetologie. Springer-Verlag. Berlin Heidelberg; Rodeck, B. et al. (2013): Pädiatrische Gastroenterologie, Hepatologie und Ernährung. 2. Auflage. Springer-Verlag. Berlin Heidelberg

FL07 - Initiation and management of uni-centric/multi-centric clinical/scientific studies

Explanation

FL01 - Lectureships / teaching posts at colleges and universities

Explanation

Prof. Dr. Albers: Medizinische Fakultät der Rheinischen Friedrich-Wilhelms-Universität Bonn, Priv.- Doz. Dr. Rodeck: Medizinische Hochschule Hannover.

FL03 - Student training (clinical traineeship / internship year)

Explanation

In Kooperation mit dem Marienhospital Osnabrück

FL09 - Doctoral supervision

Explanation

FL06 - Participation in multi-centre phase III/IV studies

Explanation

Training

Training in other healing professions

HB19 - Nursing professionals

Comment

Die Berufsfachschule Pflege am CKO verfügt über 85 Ausbildungsplätze und 3 Plätze für ein duales Studium (B. Sc.) in der Pflege. Ein Merkmal ist die Qualifikation der Pflegepädagogen mit Schwerpunkt Kinderkrankenpflege. Den Absolventen bieten sich sehr gute Perspektiven auf dem Arbeitsmarkt.

HB16 - Dietician (m/f)

Comment

Angebot von Praktika im Rahmen der Ausbildung. Zusammenarbeit mit verschiedenen Schulen aus Osnabrück und Umgebung.

HB03 - Physical therapist / physiotherapist (m/f)

Comment

Angebot von Praktika im Rahmen der Ausbildung. Zusammenarbeit mit verschiedenen Schulen aus Osnabrück und Umgebung.

HB10 - Midwife (m/f)

Comment

In Zusammenarbeit mit der Akademie Klinikum Osnabrück.

HB02 - Health and paediatric nurse (m/f)

Comment

Hospital staff
Pharmaceutical personnel
- Explanations: In Kooperation mit dem Franziskus-Hospital Harderberg (Krankenahauspotheke)
- Nursing staff regulation

Service contact persons

Patient advocates

Marlies Heermann

Patientenfürsprecherin

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6000
Mail: ed.sokc@ofni

Dr. med. Rüdiger Cording

Patientenfürsprecher

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6000
Mail: ed.sokc@ofni

Marlies Heermann

Patientenfürsprecherin

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6000
Mail: ed.sokc@ofni

Maria Schon

Patientenfürsprecher

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6000
Mail: ed.sokc@ofni

Customer feedback management

Malina Götting

Qualitätsmanagement, Qualitätssicherung, Beschwerdemanagement

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6000
Mail: ed.sokc@ofni

Malina Götting

Qualitätsmanagement, Qualitätssicherung, Beschwerdemanagement

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6000
Mail: ed.sokc@ofni

Quality management

Malina Götting

Qualitätsmanagementbeauftragte

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6000
Mail: ed.sokc@ofni

Lina Bredefeld

Qualitätsmanagementbeauftragte

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6000
Mail: ed.sokc@ofni

Hygiene officer

Dr. med. Florian Urlichs

Ärztlicher Direktor/ Chefarzt Pädiatrie / Neonatologe

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6900
Mail: ed.sokc@tairaterkes.dem

Dr. med. Florian Urlichs

Ärztlicher Direktor/ Chefarzt Pädiatrie / Neonatologe

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6900
Mail: ed.sokc@tairaterkes.dem

Responsible for drug therapy

Dr. med. Florian Urlichs

Ärztlicher Direktor

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6900
Mail: ed.sokc@tairaterkes.dem

Dr. med. Florian Urlichs

Ärztlicher Direktor

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6900
Mail: ed.sokc@tairaterkes.dem

Accessibility Officer

Malte Grautmann

Personalverwaltung

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6000
Mail: ed.sokc@ofni

Malte Grautmann

Personalverwaltung

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6000
Mail: ed.sokc@ofni

Company

General contact details of the hospital

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541-7000-6000
Mail: ed.sokc@ofni

Nursing service management

Andrea Meyer

Pflegedirektorin

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6940
Mail: ed.sokc@ofni

Andrea Meyer

Pflegedirektorin

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6940
Mail: ed.sokc@ofni

Head of administration

Michael Richter

Geschäftsführer

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6940
Mail: ed.sokc@gnurheufstfeahcseg

Michael Richter

Geschäftsführer

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6940
Mail: ed.sokc@gnurheufstfeahcseg

Responsible for the quality report in the hospital management

Michael Richter

Geschäftsführer

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6940
Mail: ed.sokc@ofni

Michael Richter

Geschäftsführer

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6940
Mail: ed.sokc@ofni

Medical management

Dr. med. Bernd Richter

Chefarzt Kinderchirurgie

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6920
Mail: ed.sokc@tairaterkes.dem

Dr. med. Florian Urlichs

Ärztlicher Direktor/Chefarzt Kinder- und Jugendmedizin/ Neonatologe

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6900
Mail: ed.sokc@tairaterkes.dem

Dr. med. Bernd Richter

Chefarzt Kinderchirurgie

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6920
Mail: ed.sokc@tairaterkes.dem

Dr. med. Florian Urlichs

Ärztlicher Direktor/Chefarzt Kinder- und Jugendmedizin/ Neonatologe

Am Finkenhügel 1
49076 Osnabrück

Phone: 0541 -7000-6900
Mail: ed.sokc@tairaterkes.dem

Regional care obligation for psychiatry?

IK number

IK: 260342183

Location number

Location number: 771128000

Old location number: 771128000